ABOUT THE RESEARCHER

OVERVIEW

Dr. McAdam's research focuses on the utility of diagnostic tests for infections of children.

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Predictive value of direct disk diffusion testing from positive blood cultures in a children's hospital and its utility in antimicrobial stewardship. J Clin Microbiol. 2021 Mar 10. View abstract
  2. Too Slow, Less Dough for SARS-CoV-2 Tests? A Micro-Comic Strip. J Clin Microbiol. 2021 01 21; 59(2). View abstract
  3. Practice Improvement for Standardized Evaluation and Management of Acute Tracheitis in Mechanically Ventilated Children. Pediatr Qual Saf. 2021 Jan-Feb; 6(1):e368. View abstract
  4. Can We Test Our Way Out of the COVID-19 Pandemic? J Clin Microbiol. 2020 10 21; 58(11). View abstract
  5. The ASM Journals Committee Values the Contributions of Black Microbiologists. J Virol. 2020 09 29; 94(20). View abstract
  6. The ASM Journals Committee Values the Contributions of Black Microbiologists. J Clin Microbiol. 2020 09 22; 58(10). View abstract
  7. The ASM Journals Committee Values the Contributions of Black Microbiologists. Antimicrob Agents Chemother. 2020 09 21; 64(10). View abstract
  8. The ASM Journals Committee Values the Contributions of Black Microbiologists. Infect Immun. 2020 09 18; 88(10). View abstract
  9. The ASM Journals Committee Values the Contributions of Black Microbiologists. Mol Cell Biol. 2020 09 14; 40(19). View abstract
  10. The ASM Journals Committee Values the Contributions of Black Microbiologists. J Bacteriol. 2020 09 08; 202(19). View abstract
  11. The ASM Journals Committee Values the Contributions of Black Microbiologists. Appl Environ Microbiol. 2020 09 01; 86(18). View abstract
  12. Is This a Critical Result? A Micro-Comic Strip. J Clin Microbiol. 2020 08 24; 58(9). View abstract
  13. The ASM Journals Committee Values the Contributions of Black Microbiologists. Microbiol Resour Announc. 2020 Jul 31; 9(32). View abstract
  14. The ASM Journals Committee Values the Contributions of Black Microbiologists. mBio. 2020 07 31; 11(4). View abstract
  15. The ASM Journals Committee Values the Contributions of Black Microbiologists. mSphere. 2020 07 31; 5(4). View abstract
  16. The ASM Journals Committee Values the Contributions of Black Microbiologists. mSystems. 2020 Jul 31; 5(4). View abstract
  17. The ASM Journals Committee Values the Contributions of Black Microbiologists. Microbiol Mol Biol Rev. 2020 08 19; 84(3). View abstract
  18. The ASM Journals Committee Values the Contributions of Black Microbiologists. Clin Microbiol Rev. 2020 09 16; 33(4). View abstract
  19. The ASM Journals Committee Values the Contributions of Black Microbiologists. J Microbiol Biol Educ. 2020; 21(2). View abstract
  20. Special Issue on Diagnostic Testing for Severe Acute Respiratory Syndrome Coronavirus 2 and Lessons from This Pandemic. J Clin Microbiol. 2020 Jul 23; 58(8). View abstract
  21. What Is Needed for the Response to COVID-19? A Micro-Comic Strip. J Clin Microbiol. 2020 Jul 23; 58(8). View abstract
  22. Practical guide for pediatric pulmonologists on imaging management of pediatric patients with COVID-19. Pediatr Pulmonol. 2020 09; 55(9):2213-2224. View abstract
  23. The ASM Journals Committee Values the Contributions of Black Microbiologists. Microbiol Spectr. 2020 07; 8(3). View abstract
  24. The Clinical Microbiology Laboratory Response to COVID-19: a Micro-Comic Strip. J Clin Microbiol. 2020 05 26; 58(6). View abstract
  25. What's Special about Cefiderocol? A Micro-Comic Strip. J Clin Microbiol. 2020 04 23; 58(5). View abstract
  26. The End of Coagulase-Negative Staphylococci? A Micro-Comic Strip. J Clin Microbiol. 2020 02 24; 58(3). View abstract
  27. The genome of opportunistic fungal pathogen Fusarium oxysporum carries a unique set of lineage-specific chromosomes. Commun Biol. 2020 01 31; 3(1):50. View abstract
  28. Enterobacteriaceae? Enterobacterales? What Should We Call Enteric Gram-Negative Bacilli? A Micro-Comic Strip. J Clin Microbiol. 2020 01 28; 58(2). View abstract
  29. Are Bacteria Sensitive or Susceptible? A Micro-Comic Strip. J Clin Microbiol. 2019 12 23; 58(1). View abstract
  30. Don't Test Me: a Micro-Comic Strip. J Clin Microbiol. 2019 12; 57(12). View abstract
  31. Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients. Nat Med. 2019 11; 25(11):1728-1732. View abstract
  32. What's That Species? A Micro-Comic Strip. J Clin Microbiol. 2019 11; 57(11). View abstract
  33. Total Laboratory Automation: a Micro-Comic Strip. J Clin Microbiol. 2019 10; 57(10). View abstract
  34. Reply to Molitor, "Susceptibility Categories Should Be Agreed Upon". J Clin Microbiol. 2019 09; 57(9). View abstract
  35. What about Serology? A Micro-Comic Strip. J Clin Microbiol. 2019 09; 57(9). View abstract
  36. The Photo Quiz: a Look Back and a Look Forward. J Clin Microbiol. 2019 09; 57(9). View abstract
  37. Improving the Laboratory Information System: a Micro-Comic Strip. J Clin Microbiol. 2019 08; 57(8). View abstract
  38. Can You Speciate This for Me? A Micro-Comic Strip. J Clin Microbiol. 2019 07; 57(7). View abstract
  39. What Is the Future of Clinical Microbiology? Clin Lab Med. 2019 09; 39(3):509-512. View abstract
  40. Epidemiological Cutoff Values: a Micro-Comic Strip. J Clin Microbiol. 2019 06; 57(6). View abstract
  41. Biographical Feature: Stephen G. Jenkins, Ph.D., D(ABMM), F(AAM). J Clin Microbiol. 2019 05; 57(5). View abstract
  42. The Significance of Microbial Taxonomy: a Micro-Comic Strip. J Clin Microbiol. 2019 05; 57(5). View abstract
  43. The Divergent Meanings of "I" for the Clinical and Laboratory Standards Institute and the European Committee on Antimicrobial Susceptibility Testing: a Micro-Comic Strip. J Clin Microbiol. 2019 04; 57(4). View abstract
  44. Whole-Genome Sequences of Staphylococcus aureus Isolates from Cystic Fibrosis Lung Infections. Microbiol Resour Announc. 2019 Jan; 8(3). View abstract
  45. Rebranding Clinical Laboratories: a Micro-Comic Strip. J Clin Microbiol. 2019 01; 57(1). View abstract
  46. Pitfalls in Performing Research in the Clinical Microbiology Laboratory: a Micro-Comic Strip. J Clin Microbiol. 2018 10; 56(10). View abstract
  47. Shotgun Metagenomic Detection of Pathogens: a Micro-Comic Strip. J Clin Microbiol. 2018 08; 56(8). View abstract
  48. Winners of the American Society for Microbiology Awards in Clinical Microbiology. J Clin Microbiol. 2018 06; 56(6). View abstract
  49. Paying for Point-of-Care Nucleic Acid Amplification Tests: a Micro-Comic Strip. J Clin Microbiol. 2018 06; 56(6). View abstract
  50. Total Laboratory Automation in Clinical Microbiology: a Micro-Comic Strip. J Clin Microbiol. 2018 04; 56(4). View abstract
  51. The Utility of Multiplex Molecular Tests for Enteric Pathogens: a Micro-Comic Strip. J Clin Microbiol. 2018 02; 56(2). View abstract
  52. The Role of Scientific and Medical Societies in Journals … and More: a Micro-Comic Strip. J Clin Microbiol. 2017 12; 55(12):3315. View abstract
  53. Ceftaroline pharmacokinetics and pharmacodynamics in patients with cystic fibrosis. J Cyst Fibros. 2018 05; 17(3):e25-e31. View abstract
  54. Sensitivity and Specificity or Positive and Negative Percent Agreement? A Micro-Comic Strip. J Clin Microbiol. 2017 11; 55(11):3153-3154. View abstract
  55. Discrepant Analysis and Bias: a Micro-Comic Strip. J Clin Microbiol. 2017 10; 55(10):2878-2879. View abstract
  56. Prevalence and Predictive Values: a Micro-Comic Strip. J Clin Microbiol. 2017 09; 55(9):2566. View abstract
  57. Reducing Contamination of Blood Cultures: Consider Costs and Clinical Benefits. Clin Infect Dis. 2017 07 15; 65(2):206-207. View abstract
  58. Unforeseen Consequences: Culture-Independent Diagnostic Tests and Epidemiologic Tracking of Foodborne Pathogens. J Clin Microbiol. 2017 07; 55(7):1978-1979. View abstract
  59. Global and local selection acting on the pathogen Stenotrophomonas maltophilia in the human lung. Nat Commun. 2017 01 19; 8:14078. View abstract
  60. A Rose by Any Other Name: Practical Updates on Microbial Nomenclature for Clinical Microbiology. J Clin Microbiol. 2017 01; 55(1):3-4. View abstract
  61. Association Between Storage Interval and Contamination of Reprocessed Flexible Endoscopes in a Pediatric Gastrointestinal Procedural Unit. Infect Control Hosp Epidemiol. 2017 02; 38(2):131-135. View abstract
  62. ASM Journals Eliminate Impact Factor Information from Journal Websites. Clin Microbiol Rev. 2016 10; 29(4):i-ii. View abstract
  63. ASM Journals Eliminate Impact Factor Information from Journal Websites. Appl Environ Microbiol. 2016 09 15; 82(18):5479-80. View abstract
  64. The Focus on Quality Publications in Journal of Clinical Microbiology. J Clin Microbiol. 2016 09; 54(9):2218. View abstract
  65. ASM Journals Eliminate Impact Factor Information from Journal Websites. Antimicrob Agents Chemother. 2016 09; 60(9):5109-10. View abstract
  66. ASM Journals Eliminate Impact Factor Information from Journal Websites. Infect Immun. 2016 09; 84(9):2407-8. View abstract
  67. The aetiology of diarrhoea, pneumonia and respiratory colonization of HIV-exposed infants randomized to breast- or formula-feeding. Paediatr Int Child Health. 2016 Aug; 36(3):189-97. View abstract
  68. Essential Microbiology for Wound Care. Clin Infect Dis. 2016 Oct 15; 63(8):1149. View abstract
  69. ASM Journals Eliminate Impact Factor Information from Journal Websites. Microbiol Mol Biol Rev. 2016 09; 80(3):i-ii. View abstract
  70. ASM Journals Eliminate Impact Factor Information from Journal Websites. mSphere. 2016 Jul-Aug; 1(4). View abstract
  71. ASM Journals Eliminate Impact Factor Information from Journal Websites. mBio. 2016 07 11; 7(4). View abstract
  72. ASM Journals Eliminate Impact Factor Information from Journal Websites. J Clin Microbiol. 2016 09; 54(9):2216-7. View abstract
  73. ASM Journals Eliminate Impact Factor Information from Journal Websites. mSystems. 2016 Jul-Aug; 1(4). View abstract
  74. Evaluation of the C6 Lyme Enzyme Immunoassay for the Diagnosis of Lyme Disease in Children and Adolescents. Clin Infect Dis. 2016 10 01; 63(7):922-8. View abstract
  75. The Brief Case: Safe To Go Back in the Water? Vibrio parahaemolyticus Wound Infection Associated with Brackish Water. J Clin Microbiol. 2016 06; 54(6):1414-1415. View abstract
  76. Closing the Brief Case: Safe To Go Back in the Water? Vibrio parahaemolyticus Wound Infection Associated with Brackish Water. J Clin Microbiol. 2016 06; 54(6):1672. View abstract
  77. Pediatric Clinical Microbiology: It's the Little Things. J Clin Microbiol. 2016 06; 54(6):1412-1413. View abstract
  78. Reply to "Case Reports May Be Declared Dead by the Journal of Clinical Microbiology, but They Are Alive and Well in JMM Case Reports". J Clin Microbiol. 2016 Feb; 54(2):503. View abstract
  79. The Brief Case: a New Feature in Journal of Clinical Microbiology. J Clin Microbiol. 2016 Mar; 54(3):512. View abstract
  80. Your Viral Past: A Comprehensive Method for Serological Profiling to Explore the Human Virome. Clin Chem. 2016 Mar; 62(3):426-7. View abstract
  81. An Obituary for the Case Report in Journal of Clinical Microbiology. J Clin Microbiol. 2015 Aug; 53(8):2396-7. View abstract
  82. The aetiology of diarrhoea, pneumonia and respiratory colonization of HIV-exposed infants randomized to breast- or formula-feeding. Paediatr Int Child Health. 2015 Jun 8; 2046905515Y0000000038. View abstract
  83. Preface. Diagnostic testing for enteric pathogens. Clin Lab Med. 2015 Jun; 35(2):xi-xii. View abstract
  84. Shiga Toxin Producing Escherichia coli. Clin Lab Med. 2015 Jun; 35(2):247-72. View abstract
  85. Point-Counterpoint: Large Multiplex PCR Panels Should Be First-Line Tests for Detection of Respiratory and Intestinal Pathogens. J Clin Microbiol. 2015 Oct; 53(10):3110-5. View abstract
  86. A happy birthday and a transition at the Journal of Clinical Microbiology. J Clin Microbiol. 2015 Jan; 53(1):2-3. View abstract
  87. What's your subtype? The epidemiologic utility of bacterial whole-genome sequencing. Clin Chem. 2014 Apr; 60(4):586-8. View abstract
  88. Genetic variation of a bacterial pathogen within individuals with cystic fibrosis provides a record of selective pressures. Nat Genet. 2014 Jan; 46(1):82-7. View abstract
  89. Yield of fungal surveillance cultures in pediatric hematopoietic stem cell transplant patients: a retrospective analysis and survey of current practice. Clin Infect Dis. 2014 Feb; 58(3):365-71. View abstract
  90. Interferon ?-release assays for diagnosis of latent tuberculosis in healthcare workers in low-incidence settings: pros and cons. Clin Chem. 2014 May; 60(5):714-8. View abstract
  91. Polymerase chain reaction test for Clostridium difficile toxin B gene reveals similar prevalence rates in children with and without inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2013 Sep; 57(3):293-7. View abstract
  92. Biographical feature: Eileen L. Randall, Ph.D. J Clin Microbiol. 2013 Nov; 51(11):3476-7. View abstract
  93. Identifying antibiotic-resistant bacteria in hospitalized patients: what is the role of active-surveillance cultures? Clin Chem. 2013 Nov; 59(11):1556-60. View abstract
  94. Changing epidemiology of methicillin-resistant Staphylococcus aureus colonization in paediatric intensive-care units. Epidemiol Infect. 2013 Sep; 141(9):1983-92. View abstract
  95. Hand, foot, and mouth disease caused by coxsackievirus a6. Emerg Infect Dis. 2012 Oct; 18(10):1702-4. View abstract
  96. John C. Sherris, M.D. J Clin Microbiol. 2012 Nov; 50(11):3416-7. View abstract
  97. Nasopharyngeal lactate dehydrogenase concentrations predict bronchiolitis severity in a prospective multicenter emergency department study. Pediatr Infect Dis J. 2012 Jul; 31(7):767-9. View abstract
  98. Antibiotic resistance: how serious is the problem, and what can be done? Clin Chem. 2012 Aug; 58(8):1182-6. View abstract
  99. Impact of in-hospital enteroviral polymerase chain reaction testing on the clinical management of children with meningitis. J Hosp Med. 2012 Sep; 7(7):517-20. View abstract
  100. Photo quiz: an 11-year-old with abdominal pain. J Clin Microbiol. 2012 Apr; 50(4):1139, 1508. View abstract
  101. Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection. J Infect Dis. 2012 Jun; 205(11):1709-18. View abstract
  102. Molecular testing for infectious diseases should be done in the clinical microbiology laboratory. J Clin Microbiol. 2012 Jun; 50(6):1836-40. View abstract
  103. A high-throughput screen identifies a new natural product with broad-spectrum antibacterial activity. PLoS One. 2012; 7(2):e31307. View abstract
  104. Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nat Genet. 2011 Nov 13; 43(12):1275-80. View abstract
  105. Improved sensitivity of a commercial reverse transcription-PCR test for subtyping of the 2009 H1N1 influenza A virus. J Clin Microbiol. 2011 Mar; 49(3):1188. View abstract
  106. Shiga toxin-producing Escherichia coli in children: diagnosis and clinical manifestations of O157:H7 and non-O157:H7 infection. J Clin Microbiol. 2011 Mar; 49(3):955-9. View abstract
  107. Streptococcus milleri group pleuropulmonary infection in children: computed tomographic findings and clinical features. J Comput Assist Tomogr. 2010 Nov-Dec; 34(6):927-32. View abstract
  108. Higher prevalence of pharyngeal than nasal Staphylococcus aureus carriage in pediatric intensive care units. J Clin Microbiol. 2010 Aug; 48(8):2957-9. View abstract
  109. Trimethoprim in vitro antibacterial activity is not increased by adding sulfamethoxazole for pediatric Escherichia coli urinary tract infection. J Urol. 2010 Jul; 184(1):305-10. View abstract
  110. Multicenter study of clinical performance of the 3M Rapid Detection RSV test. J Clin Microbiol. 2010 Jul; 48(7):2337-43. View abstract
  111. Re-emergence of the type 1 pilus among Streptococcus pneumoniae isolates in Massachusetts, USA. Vaccine. 2010 Jul 05; 28(30):4842-6. View abstract
  112. Human metapneumovirus. Clin Lab Med. 2010 Mar; 30(1):131-48. View abstract
  113. Test characteristics of commercial influenza assays for detecting pandemic influenza A (H1N1) in children. Pediatr Infect Dis J. 2010 Mar; 29(3):261-2. View abstract
  114. Swine-origin influenza a (H1N1) viral infection in children: initial chest radiographic findings. Radiology. 2010 Mar; 254(3):934-41. View abstract
  115. Respiratory viruses in pediatric and adult populations. Preface. Clin Lab Med. 2009 Dec; 29(4):xi-xii. View abstract
  116. Developments in tissue culture detection of respiratory viruses. Clin Lab Med. 2009 Dec; 29(4):623-34. View abstract
  117. Relative impact of influenza and respiratory syncytial virus in young children. Pediatrics. 2009 Dec; 124(6):e1072-80. View abstract
  118. Epidemiology and risk factors for Staphylococcus aureus colonization in children in the post-PCV7 era. BMC Infect Dis. 2009 Jul 11; 9:110. View abstract
  119. Prospective multicenter study of the viral etiology of bronchiolitis in the emergency department. Acad Emerg Med. 2008 Feb; 15(2):111-8. View abstract
  120. Association of the pneumococcal pilus with certain capsular serotypes but not with increased virulence. J Clin Microbiol. 2007 Jun; 45(6):1684-9. View abstract
  121. Influenza and other respiratory virus-related emergency department visits among young children. Pediatrics. 2006 Jul; 118(1):e1-8. View abstract
  122. Validation of syndromic surveillance for respiratory infections. Ann Emerg Med. 2006 Mar; 47(3):265.e1. View abstract
  123. Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis. Am J Respir Crit Care Med. 2006 Feb 15; 173(4):421-5. View abstract
  124. Cerebrospinal latex agglutination fails to contribute to the microbiologic diagnosis of pretreated children with meningitis. Pediatr Infect Dis J. 2004 Aug; 23(8):786-8. View abstract
  125. Pathology of human metapneumovirus infection: insights into the pathogenesis of a newly identified respiratory virus. Pediatr Dev Pathol. 2004 Sep-Oct; 7(5):478-86; discussion 421. View abstract
  126. Human metapneumovirus in children tested at a tertiary-care hospital. J Infect Dis. 2004 Jul 01; 190(1):20-6. View abstract
  127. Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area. J Clin Microbiol. 2004 Apr; 42(4):1559-63. View abstract
  128. Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin. J Clin Microbiol. 2004 Mar; 42(3):1263-4. View abstract
  129. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics. 2004 Mar; 113(3 Pt 1):585-93. View abstract
  130. Human metapneumovirus--an important new respiratory virus. N Engl J Med. 2004 Jan 29; 350(5):431-3. View abstract
  131. Cutting edge: inducible costimulator protein regulates both Th1 and Th2 responses to cutaneous leishmaniasis. J Immunol. 2002 Feb 01; 168(3):991-5. View abstract
  132. ICOS is critical for CD40-mediated antibody class switching. Nature. 2001 Jan 04; 409(6816):102-5. View abstract
  133. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells. J Immunol. 2000 Nov 01; 165(9):5035-40. View abstract
  134. Either B7 costimulation or IL-2 can elicit generation of primary alloreactive CTL. J Immunol. 2000 Sep 15; 165(6):3088-93. View abstract
  135. Discrepant analysis: how can we test a test? J Clin Microbiol. 2000 Jun; 38(6):2027-9. View abstract
  136. B7 costimulation is critical for antibody class switching and CD8(+) cytotoxic T-lymphocyte generation in the host response to vesicular stomatitis virus. J Virol. 2000 Jan; 74(1):203-8. View abstract
  137. Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions. Immunity. 1999 Dec; 11(6):689-98. View abstract
  138. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts. J Immunol. 1999 Oct 01; 163(7):3753-7. View abstract
  139. B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). J Exp Med. 1999 Jan 18; 189(2):435-40. View abstract
  140. The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells. Immunol Rev. 1998 Oct; 165:231-47. View abstract
  141. IL-3 enhances both presentation of exogenous particulate antigen in association with class I major histocompatibility antigen and generation of primary tumor-specific cytolytic T lymphocytes. J Immunol. 1998 Jun 15; 160(12):5773-80. View abstract
  142. Expression of human prostate-specific antigen (PSA) in a mouse tumor cell line reduces tumorigenicity and elicits PSA-specific cytotoxic T lymphocytes. Cancer Immunol Immunother. 1996 Jul; 42(6):362-8. View abstract
  143. Analysis of the effect of cytokines (interleukins 2, 3, 4, and 6, granulocyte-monocyte colony-stimulating factor, and interferon-gamma) on generation of primary cytotoxic T lymphocytes against a weakly immunogenic tumor. Cell Immunol. 1995 Oct 15; 165(2):183-92. View abstract
  144. B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma. Cell Immunol. 1995 Oct 15; 165(2):217-24. View abstract
  145. Synergistic effects of co-expression of the TH1 cytokines IL-2 and IFN-gamma on generation of murine tumor-reactive cytotoxic cells. Int J Cancer. 1995 May 29; 61(5):628-34. View abstract
  146. Transfection of transforming growth factor-beta producing tumor EMT6 with interleukin-2 elicits tumor rejection and tumor reactive cytotoxic T-lymphocytes. J Immunother Emphasis Tumor Immunol. 1994 Apr; 15(3):155-64. View abstract
  147. Isolation and expansion of tumor-infiltrating lymphocytes. Biotechniques. 1993 Dec; 15(6):970-2. View abstract
  148. Interleukin-3 inhibits the generation of nonspecific killers by interleukin-2. J Immunother Emphasis Tumor Immunol. 1993 Nov; 14(4):293-7. View abstract
  149. Coexpression of IL-2 and gamma-IFN enhances tumor immunity. Ann N Y Acad Sci. 1993 Aug 12; 690:349-51. View abstract
  150. Transfection of TGF-beta producing tumors with IL-2 elicits tumor rejection. Ann N Y Acad Sci. 1993 Aug 12; 690:346-8. View abstract
  151. Interleukin 3 enhances development of tumor-reactive cytotoxic cells by a CD4-dependent mechanism. Cancer Res. 1993 May 01; 53(9):2112-7. View abstract
  152. CD4-class II major histocompatibility complex interaction does not enhance killing by a class I-restricted CD4+CD8+ cytotoxic T cell clone. Eur J Immunol. 1992 Sep; 22(9):2461-4. View abstract
  153. Mechanism of cytolytic T lymphocyte killing of a low class I-expressing tumor. J Immunol. 1991 Aug 15; 147(4):1433-8. View abstract
  154. Class-I MHC expression in the mouse lung carcinoma, line 1: a model for class-I inducible tumors. Int J Cancer Suppl. 1991; 6:82-9. View abstract
  155. Thyroid hormone status regulates preprotachykinin-A gene expression in male rat anterior pituitary. Endocrinology. 1987 Oct; 121(4):1555-61. View abstract